May your semaglutide stay potent, your provider stay responsive, and your results stay consistent.
How should I store my IGF-1 LR3 before and after reconstitution
Investigational anti-hyperglycemic agents: the future of type 2 diabetes therapy
GLP-1 medications are a class of medications that first came to market in 2005 for the treatment of type 2 diabetes and later in 2014, for obesity
Unregulated or black-market semaglutide and tirzepatide may contain incorrect doses, impurities, or counterfeit formulations that can cause severe complications including pancreatitis, gallbladder disease, thyroid changes, or allergic reactions
After the initial month and a half, side effects should subside or become more tolerable